Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Alexander Gottschalk, MD, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentRadiation Oncology
    Address1600 Divisadero
    San Francisco CA 94115
    Phone415-353-7185
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of ChicagoM.D.School of Medicine1996

      Collapse ORNG Applications 
      Collapse Websites
      Collapse Clinical Trials

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558. PMID: 27711167.
        View in: PubMed
      2. Woodard GA, Crockard JC, Clary-Macy C, Zoon-Besselink CT, Jones K, Korn WM, Ko AH, Gottschalk AR, Rogers SJ, Jablons DM. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity. J Surg Oncol. 2016 Dec; 114(7):838-847. PMID: 27569043.
        View in: PubMed
      3. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. PMID: 24441584.
        View in: PubMed
      4. Anwar M, Weinberg V, Seymour Z, Hsu IJ, Roach M, Gottschalk AR. Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer. Radiat Oncol. 2016; 11(1):8. PMID: 26792201.
        View in: PubMed
      5. McGuinness CM, Gottschalk AR, Lessard E, Nakamura JL, Pinnaduwage D, Pouliot J, Sims C, Descovich M. Investigating the clinical advantages of a robotic linac equipped with a multileaf collimator in the treatment of brain and prostate cancer patients. J Appl Clin Med Phys. 2015; 16(5):5502. PMID: 26699309.
        View in: PubMed
      6. Tinkle CL, Weinberg V, Braunstein SE, Wustrack R, Horvai A, Jahan T, O'Donnell RJ, Gottschalk AR. Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma. Sarcoma. 2015; 2015:913565. PMID: 26346118; PMCID: PMC4546758.
      7. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. PMID: 26198421.
        View in: PubMed
      8. Bomberg H, Albert N, Schmitt K, Gräber S, Kessler P, Steinfeldt T, Hering W, Gottschalk A, Standl T, Stork J, Meißner W, Teßmann R, Geiger P, Koch T, Spies CD, Volk T, Kubulus C. Obesity in regional anesthesia--a risk factor for peripheral catheter-related infections. Acta Anaesthesiol Scand. 2015 Sep; 59(8):1038-48. PMID: 26040788.
        View in: PubMed
      9. Seymour ZA, Chang AJ, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-72. PMID: 25795252.
        View in: PubMed
      10. Descovich M, McGuinness C, Kannarunimit D, Chen J, Pinnaduwage D, Pouliot J, Kased N, Gottschalk AR, Yom SS. Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: insights from lung tumor patients treated with robotic radiosurgery. Med Phys. 2015 Mar; 42(3):1280-7. PMID: 25735283.
        View in: PubMed
      11. Gustafson GS, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Hsu IC, Lloyd S, Mclaughlin PW, Merrick GS, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ. ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer. Oncology (Williston Park). 2014 Dec; 28(12):1125-30, 1132-6. PMID: 25510812.
        View in: PubMed
      12. Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom SS. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Technol Cancer Res Treat. 2015 Feb; 14(1):49-60. PMID: 24325136.
        View in: PubMed
      13. Schnabel A, Middendorf B, Boschin MG, Gottschalk A, Van Aken H, Zahn PK, Pogatzki-Zahn EM. [Differences of analgesic efficacy and complication rates between ultrasound and nervestimulator guided peripheral nerve catheters : Database analysis on patient-relevant target parameters]. Anaesthesist. 2014 Nov; 63(11):825-31. PMID: 25227880.
        View in: PubMed
      14. Alexander J, Weinberg V, Gottschalk AR, Hsu IC, Shinohara K, Roach M. Pre-plan parameters predict post-implant D90 = 140 Gy for (125)I permanent prostate implants. J Contemp Brachytherapy. 2014 Jun; 6(2):143-53. PMID: 25097554; PMCID: PMC4105644.
      15. Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2014 Jun; 37(3):278-88. PMID: 25180754.
        View in: PubMed
      16. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. Response to Drs Rogers, Hayes, and Demanes. Brachytherapy. 2014 Sep-Oct; 13(5):523-5. PMID: 24880587.
        View in: PubMed
      17. Gottschalk A. Commentary on "Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus." Kalakota K, Liauw SL, Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, IL.: Urology 2013;81(6):1196-201. doi: 10.1016/j.urology.2013.01.047. [Epub 2013 Mar 26]. Urol Oncol. 2014 Apr; 32(3):374. PMID: 24679464.
        View in: PubMed
      18. Gottschalk A. Commentary on "Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer." Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Harvard Radiation Oncology Program, Boston, MA.: Cancer 2013;119(9):1729-35. doi: 10.1002/cncr.27956. [Epub 2013 Feb 22]. Urol Oncol. 2014 Apr; 32(3):373-4. PMID: 24679463.
        View in: PubMed
      19. Gottschalk A. Commentary on "A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma." Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Victoria, Australia.: BJU Int 2012;110(11 Pt B):E737-43. doi: 10.1111/j.1464-410X.2012.11550.x. [Epub 2012 Oct 29]. Urol Oncol. 2014 Apr; 32(3):374-5. PMID: 24679465.
        View in: PubMed
      20. Johnson LL, Delano M, Spector M, Pittsley A, Gottschalk A. The Long-Term Clinical Outcomes Following Autogenous Bone Grafting for Large-Volume Defects of the Knee: 12- to 21-Year Follow-Up. Cartilage. 2014 Apr; 5(2):86-96. PMID: 26069688; PMCID: PMC4297077.
      21. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes. PLoS One. 2014; 9(3):e89754. PMID: 24594774; PMCID: PMC3940667.
      22. Anwar M, Weinberg V, Chang AJ, Hsu IC, Roach M, Gottschalk A. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir. Radiat Oncol. 2014; 9:42. PMID: 24484652; PMCID: PMC3923240.
      23. Gottschalk A. Commentary on "secondary cancers after intensity-modulated radiotherapy, brachytherapy, and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention." Zelefsky MJ, Pei X, Teslova T, Kuk D, Magsanoc JM, Kollmeier M, Cox B, Zhang Z. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.: BJU Int 2012;110:1696-701. doi: 10.1111/j.1464-410X.2012.11385.x. [Epub 2012 Aug 13]. Urol Oncol. 2014 Feb; 32(2):209. PMID: 24445290.
        View in: PubMed
      24. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2014 Jan-Feb; 13(1):27-31. PMID: 24368283.
        View in: PubMed
      25. Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiother Oncol. 2013 Nov; 109(2):246-50. PMID: 24231238; PMCID: PMC4081029.
      26. Descovich M, Carrara M, Morlino S, Pinnaduwage DS, Saltiel D, Pouliot J, Nash MB, Pignoli E, Valdagni R, Roach M, Gottschalk AR. Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife. J Appl Clin Med Phys. 2013; 14(5):162-72. PMID: 24036869.
        View in: PubMed
      27. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):324-9. PMID: 23474112.
        View in: PubMed
      28. Eberhardt SC, Carter S, Casalino DD, Merrick G, Frank SJ, Gottschalk AR, Leyendecker JR, Nguyen PL, Oto A, Porter C, Remer EM, Rosenthal SA. ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance. J Am Coll Radiol. 2013 Feb; 10(2):83-92. PMID: 23374687.
        View in: PubMed
      29. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206. PMID: 23289478.
        View in: PubMed
      30. Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012 Aug; 109(2):253-9. PMID: 22705968.
        View in: PubMed
      31. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 1; 85(2):370-7. PMID: 22672747.
        View in: PubMed
      32. Shiao SL, Sahgal A, Hu W, Jabbari S, Chuang C, Descovich M, Hsu IC, Gottschalk AR, Roach M, Ma L. Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy. Phys Med Biol. 2011 Dec 21; 56(24):7767-75. PMID: 22107791.
        View in: PubMed
      33. Vidal-Gadea A, Topper S, Young L, Crisp A, Kressin L, Elbel E, Maples T, Brauner M, Erbguth K, Axelrod A, Gottschalk A, Siegel D, Pierce-Shimomura JT. Caenorhabditis elegans selects distinct crawling and swimming gaits via dopamine and serotonin. Proc Natl Acad Sci U S A. 2011 Oct 18; 108(42):17504-9. PMID: 21969584; PMCID: PMC3198358.
      34. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):228-34. PMID: 21183287.
        View in: PubMed
      35. Stein PD, Sostman HD, Dalen JE, Bailey DL, Bajc M, Goldhaber SZ, Goodman LR, Gottschalk A, Hull RD, Matta F, Pistolesi M, Tapson VF, Weg JG, Wells PS, Woodard PK. Controversies in diagnosis of pulmonary embolism. Clin Appl Thromb Hemost. 2011 Apr; 17(2):140-9. PMID: 21159701.
        View in: PubMed
      36. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, Hsu IC. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):222-7. PMID: 21163586.
        View in: PubMed
      37. Burk TF, Horvai AE, Gottschalk AR, Leong SP, Kashani-Sabet M, Goldsby RE, Law J, O'Donnell RJ. Patellar metastatic melanoma in a 13-year-old boy. Am J Orthop (Belle Mead NJ). 2010 Dec; 39(12):582-6. PMID: 21720575.
        View in: PubMed
      38. Stein PD, Chenevert TL, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Jablonski KA, Leeper KV, Naidich DP, Sak DJ, Sostman HD, Tapson VF, Weg JG, Woodard PK. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med. 2010 Apr 6; 152(7):434-43, W142-3. PMID: 20368649; PMCID: PMC3138428.
      39. Faddegon BA, Aubin M, Bani-Hashemi A, Gangadharan B, Gottschalk AR, Morin O, Sawkey D, Wu V, Yom SS. Comparison of patient megavoltage cone beam CT images acquired with an unflattened beam from a carbon target and a flattened treatment beam. Med Phys. 2010 Apr; 37(4):1737-41. PMID: 20443494.
        View in: PubMed
      40. Sawkey D, Lu M, Morin O, Aubin M, Yom SS, Gottschalk AR, Bani-Hashemi A, Faddegon BA. A diamond target for megavoltage cone-beam CT. Med Phys. 2010 Mar; 37(3):1246-53. PMID: 20384262.
        View in: PubMed
      41. Hossain S, Xia P, Huang K, Descovich M, Chuang C, Gottschalk AR, Roach M, Ma L. Dose gradient near target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Sep 1; 78(1):58-63. PMID: 20133073.
        View in: PubMed
      42. Jabbari S, Weinberg VK, Shinohara K, Speight JL, Gottschalk AR, Hsu IC, Pickett B, McLaughlin PW, Sandler HM, Roach M. Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost. Int J Radiat Oncol Biol Phys. 2010 Jan 1; 76(1):36-42. PMID: 19409729.
        View in: PubMed
      43. Ma L, Sahgal A, Hossain S, Chuang C, Descovich M, Huang K, Gottschalk A, Larson DA. Nonrandom intrafraction target motions and general strategy for correction of spine stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):1261-5. PMID: 19647951.
        View in: PubMed
      44. Jabbari S, Hsu IC, Kawakami J, Weinberg VK, Speight JL, Gottschalk AR, Roach M, Shinohara K. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. Brachytherapy. 2009 Oct-Dec; 8(4):339-44. PMID: 19428310.
        View in: PubMed
      45. Cheung J, Aubry JF, Yom SS, Gottschalk AR, Celi JC, Pouliot J. Dose recalculation and the Dose-Guided Radiation Therapy (DGRT) process using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys. 2009 Jun 1; 74(2):583-92. PMID: 19345518.
        View in: PubMed
      46. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M, Shinohara K. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 2009 Sep; 104(5):600-4. PMID: 19245439.
        View in: PubMed
      47. Aubry JF, Cheung J, Morin O, Gottschalk A, Beaulieu L, Pouliot J. Correction of megavoltage cone-beam CT images of the pelvic region based on phantom measurements for dose calculation purposes. J Appl Clin Med Phys. 2009; 10(1):2852. PMID: 19223832.
        View in: PubMed
      48. Hossain S, Xia P, Chuang C, Verhey L, Gottschalk AR, Mu G, Ma L. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys. 2008 Sep; 35(9):4041-8. PMID: 18841856.
        View in: PubMed
      49. Chan LW, Xia P, Gottschalk AR, Akazawa M, Scala M, Pickett B, Hsu IC, Speight J, Roach M. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Sep 1; 72(1):69-77. PMID: 18342454.
        View in: PubMed
      50. Stein PD, Beemath A, Matta F, Weg JG, Yusen RD, Hales CA, Hull RD, Leeper KV, Sostman HD, Tapson VF, Buckley JD, Gottschalk A, Goodman LR, Wakefied TW, Woodard PK. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med. 2007 Oct; 120(10):871-9. PMID: 17904458; PMCID: PMC2071924.
      51. Gottschalk A, Stein PD, Sostman HD, Matta F, Beemath A. Very low probability interpretation of V/Q lung scans in combination with low probability objective clinical assessment reliably excludes pulmonary embolism: data from PIOPED II. J Nucl Med. 2007 Sep; 48(9):1411-5. PMID: 17785726.
        View in: PubMed
      52. Morin O, Gillis A, Descovich M, Chen J, Aubin M, Aubry JF, Chen H, Gottschalk AR, Xia P, Pouliot J. Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys. 2007 May; 34(5):1819-27. PMID: 17555263.
        View in: PubMed
      53. Stein PD, Beemath A, Quinn DA, Olson RE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV, Sostman HD, Weg JG, Woodard PK. Usefulness of multidetector spiral computed tomography according to age and gender for diagnosis of acute pulmonary embolism. Am J Cardiol. 2007 May 1; 99(9):1303-5. PMID: 17478162.
        View in: PubMed
      54. Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J, Hsu IC, Shinohara K, Roach M. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):610-9. PMID: 17236978.
        View in: PubMed
      55. Stein PD, Woodard PK, Weg JG, Wakefield TW, Tapson VF, Sostman HD, Sos TA, Quinn DA, Leeper KV, Hull RD, Hales CA, Gottschalk A, Goodman LR, Fowler SE, Buckley JD. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology. 2007 Jan; 242(1):15-21. PMID: 17185658.
        View in: PubMed
      56. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M, Hsu IC. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1106-12. PMID: 17197119.
        View in: PubMed
      57. Freitag M, Zbieranek K, Gottschalk A, Bubenheim M, Winter R, Tuszynski S, Standl TG. Comparative study of different concentrations of prilocaine and ropivacaine for intraoperative axillary brachial plexus block. Eur J Anaesthesiol. 2006 Jun; 23(6):481-6. PMID: 16507196.
        View in: PubMed
      58. Tran QN, Kim AC, Gottschalk AR, Wara WM, Phillips TL, O'donnell RJ, Weinberg V, Haas-Kogan DA. Clinical outcomes of intraoperative radiation therapy for extremity sarcomas. Sarcoma. 2006; 2006(1):91671. PMID: 17040093; PMCID: PMC1557794.
      59. Gottschalk AR, Doan A, Nakamura JL, Stokoe D, Haas-Kogan DA. Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1221-7. PMID: 16253776.
        View in: PubMed
      60. Gottschalk A, Danz B, Völk M. [Infratentorial progressive multifocal leukoencephalopathy in a patient with pulmonary sarcoidosis]. Rofo. 2005 Nov; 177(11):1583-5. PMID: 16302142.
        View in: PubMed
      61. Master VA, Gottschalk AR, Kane C, Carroll PR. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005 Aug; 174(2):473-7; discussion 477. PMID: 16006867.
        View in: PubMed
      62. Gottschalk AR, Doan A, Nakamura JL, Haas-Kogan DA, Stokoe D. Inhibition of phosphatidylinositol-3-kinase causes cell death through a protein kinase B (PKB)-dependent mechanism and growth arrest through a PKB-independent mechanism. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1183-8. PMID: 15752900.
        View in: PubMed
      63. Nakamura JL, Karlsson A, Arvold ND, Gottschalk AR, Pieper RO, Stokoe D, Haas-Kogan DA. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. J Neurooncol. 2005 Feb; 71(3):215-22. PMID: 15735908.
        View in: PubMed
      64. Hsu IC, Cabrera AR, Weinberg V, Speight J, Gottschalk AR, Roach M, Shinohara K. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy. 2005; 4(3):202-6. PMID: 16182220.
        View in: PubMed
      65. Kress B, Gottschalk A, Anders L, Stippich C, Palm F, Bähren W, Sartor K. High-resolution dental magnetic resonance imaging of inferior alveolar nerve responses to the extraction of third molars. Eur Radiol. 2004 Aug; 14(8):1416-20. PMID: 15007618.
        View in: PubMed
      66. Gottschalk AR, Roach M. The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials. Br J Cancer. 2004 Mar 8; 90(5):950-4. PMID: 14997188; PMCID: PMC2409615.
      67. Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, Lowther D, Liu YM, Shinohara K, Verhey LJ, Weinberg V, Roach M. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 1; 57(3):635-44. PMID: 14529767.
        View in: PubMed
      68. Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk AR, Nicholas MK, Stokoe D, Haas-Kogan DA. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res. 2002 May; 8(5):1100-6. PMID: 12006525.
        View in: PubMed
      69. Kress BP, Griesbeck F, Efinger K, Gottschalk A, Nissen S, Goriup A, Solbach T, Kornhuber AW, Bähren W. [The prognostic value of quantified MRI at an early stage of Bell's palsy]. Rofo. 2002 Apr; 174(4):426-32. PMID: 11960404.
        View in: PubMed
      70. Kress BP, Griesbeck F, Efinger K, Solbach T, Gottschalk A, Kornhuber AW, Bähren W. Bell's palsy: what is the prognostic value of measurements of signal intensity increases with contrast enhancement on MRI? Neuroradiology. 2002 May; 44(5):428-33. PMID: 12012129.
        View in: PubMed
      71. Götz ME, Janetzky B, Pohli S, Gottschalk A, Gsell W, Tatschner T, Ransmayr G, Leblhuber F, Gerlach M, Reichmann H, Riederer P, Böning J. Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link? Alcohol Clin Exp Res. 2001 May; 25(5):717-25. PMID: 11371721.
        View in: PubMed
      72. Gottschalk AR, Basila D, Wong M, Dean NM, Brandts CH, Stokoe D, Haas-Kogan DA. p27Kip1 is required for PTEN-induced G1 growth arrest. Cancer Res. 2001 Mar 1; 61(5):2105-11. PMID: 11280773.
        View in: PubMed
      73. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D, Giaccia AJ. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 2000 Feb 15; 14(4):391-6. PMID: 10691731; PMCID: PMC316386.
      74. Maldjian JA, Gottschalk A, Patel RS, Pincus D, Detre JA, Alsop DC. Mapping of secondary somatosensory cortex activation induced by vibrational stimulation: an fMRI study. Brain Res. 1999 Apr 10; 824(2):291-5. PMID: 10196461.
        View in: PubMed
      75. Wiesner DA, Kilkus JP, Gottschalk AR, Quintáns J, Dawson G. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J Biol Chem. 1997 Apr 11; 272(15):9868-76. PMID: 9092523.
        View in: PubMed
      76. Henry JW, Stein PD, Gottschalk A, Relyea B, Leeper KV. Scintigraphic lung scans and clinical assessment in critically ill patients with suspected acute pulmonary embolism. Chest. 1996 Feb; 109(2):462-6. PMID: 8620723.
        View in: PubMed
      77. Ogilvie MD, Gottschalk A, Anders K, Richter DW, Pack AI. A network model of respiratory rhythmogenesis. Am J Physiol. 1992 Oct; 263(4 Pt 2):R962-75. PMID: 1415810.
        View in: PubMed
      78. Stein PD, Terrin ML, Gottschalk A, Alavi A, Henry JW. Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism. Am J Cardiol. 1992 May 1; 69(14):1239-41. PMID: 1575198.
        View in: PubMed
      79. Pack AI, Cola MF, Goldszmidt A, Ogilvie MD, Gottschalk A. Correlation between oscillations in ventilation and frequency content of the electroencephalogram. J Appl Physiol (1985). 1992 Mar; 72(3):985-92. PMID: 1568995.
        View in: PubMed
      80. Choi BW, Berger HJ, Schwartz PE, Alexander J, Wackers FJ, Gottschalk A, Zaret BL. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Am Heart J. 1983 Oct; 106(4 Pt 1):638-43. PMID: 6613807.
        View in: PubMed
      81. Kirkwood JM, Myers JE, Vlock DR, Neumann R, Ariyan S, Gottschalk A, Hoffer P. Tomographic gallium-67 citrate scanning. Useful new surveillance for metastatic melanoma. Ann Surg. 1983 Jul; 198(1):102-7. PMID: 6859984; PMCID: PMC1352941.
      82. Kirkwood JM, Myers JE, Vlock DR, Neumann R, Ariyan S, Gottschalk A, Hoffer P. Tomographic gallium-67 citrate scanning: useful new surveillance for metastatic melanoma. Ann Intern Med. 1982 Nov; 97(5):694-9. PMID: 7137734.
        View in: PubMed
      83. Alexander J, Dainiak N, Berger HJ, Goldman L, Johnstone D, Reduto L, Duffy T, Schwartz P, Gottschalk A, Zaret BL. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med. 1979 Feb 8; 300(6):278-83. PMID: 759880.
        View in: PubMed
      84. Bekerman C, Moran EM, Hoffer PB, Hendrix RW, Gottschalk A. Scintigraphic evaluation of lymphoma: a comparative study of 67Ga-citrate and 111In-Bleomycin. Radiology. 1977 Jun; 123(3):687-94. PMID: 860022.
        View in: PubMed
      85. Gottschalk A, Usher MS, Turner DA, Polcyn RE, Quinn JL. The scintillation camera with diverging collimator: physical parameters and a clinical evaluation. Semin Nucl Med. 1971 Apr; 1(2):206-15. PMID: 5097788.
        View in: PubMed
      86. GOTTSCHALK A, MCCORMACK KR, ADAMS JE, ANGER HO. A COMPARISON OF RESULTS OF BRAIN SCANNING USING GA68-EDTA AND THE POSITRON SCINTILLATION CAMERA, WITH HG203-NEOHYDRIN AND THE CONVENTIONAL FOCUSED COLLIMATOR SCANNER. Radiology. 1965 Mar; 84:502-6. PMID: 14280725.
        View in: PubMed
      87. D ANGIO GJ, LAWRENCE JH, GOTTSCHALK A, LYMAN J. RELATIVE EFFICIENCY OF HIGH-LET RADIATION (BRAGG-PEAK LITHIUM IONS) ON NORMAL RABBIT SKIN, USING INTEGRAL DOSE AS A BASIS FOR COMPARISON. Nature. 1964 Dec 26; 204:1267-8. PMID: 14254405.
        View in: PubMed
      Alexander's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP